NEUBERGER BERMAN GROUP LLC

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1465109 NEW YORK, NY

Position in TAK

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,759,843

+$781,914 QoQ

Shares Held

95,024

+51.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 98.75924776106837.ToString("F0")% Shared 0.ToString("F0")% None 1.240752238931627.ToString("F0")%

Healthcare · as of Mar 31, 2026

NEUBERGER BERMAN GROUP LLC holds $293,250,036 across 24 Drug Manufacturers - Specialty & Generic names. TAK ranks #9 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRGO	PERRIGO Co plc	10,460,080	$112,341,259
2	ZTS	Zoetis Inc.	866,525	$102,431,919
3	AMRX	Amneal Pharmaceuticals, Inc.	3,682,284	$45,770,789
4	HLN	Haleon plc	935,229	$9,361,642
5	ALKS	Alkermes plc.	197,220	$6,973,699
6	VTRS	Viatris Inc	239,842	$3,240,265
7	UTHR	UNITED THERAPEUTICS Corp	3,821	$2,265,775
8	ELAN	Elanco Animal Health Inc	82,020	$1,962,738

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,759,843	95,024	+51.5%	Shares	Defined	2026-05-14
2025-12-31	$977,929	62,728	+29.5%	Shares	Defined	2026-02-13
2025-09-30	$709,366	48,454	+41.5%	Shares	Defined	2025-11-12
2025-06-30	$529,380	34,242	+11.5%	Shares	Defined	2025-08-25
2025-03-31	$456,642	30,709	+19.6%	Shares	Defined	2025-05-13
2024-12-31	$339,936	25,675	+54.7%	Shares	Defined	2025-02-13
2024-09-30	$235,966	16,594	+58.1%	Shares	Defined	2024-11-14
2024-06-30	$135,791	10,494	-34.5%	Shares	Defined	2024-11-14
2024-03-31	$222,614	16,027	+48.3%	Shares	Defined	2024-11-14
2020-03-31	$164,065	10,808	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.